Participants were randomized to receive prophylactic treatment with 20 mg of dexamethasone and a 5HT3 receptor antagonist ( RA ) on the day of chemotherapy , followed by gabapentin 300 mg twice a day and dexamethasone ( dex ) or placebo and dex after HEC .